Targeted therapy of diffuse large cell lymphoma
EHA Library, Anas Younes, 2160
Treating diffuse large B-cell lymphoma: optimizing the use of anti-CD20 antibodies
EHA Library, Gilles Salles, 2159
Hodgkin lymphoma in the elderly: current status and future directions
EHA Library, Stephen Proctor, 2156
Biology of Hodgkin lymphoma
EHA Library, Daniel Re, 2155
Immunological and clinical aspects of double cord blood transplants
EHA Library, Claudio Brunstein, 2123
Allogeneic transplants and immune intervention in multiple myeloma
EHA Library, Henk Lokhorst, 2124
Treatment of relapsed multiple myeloma
EHA Library, Jesús San Miguel, 2148
Frontline treatment in multiple myeloma patients ineligible for stem cell transplantation
EHA Library, Thierry Facon, 2147
Clinical implications of genetic abnormalities in myeloma
EHA Library, Johannes Drach, 2146
Molecular control of hemoglobin F production and the implications for therapy
EHA Library, Swee Lay Thein, 2135
New advances in iron chelation
EHA Library, Renzo Galanello, 2136
Management of immune thrombocytopenic purpura in adults
EHA Library, James Bussel, 2142
Immunopathogenesis, immunomodulation and management of immune thrombocytopenic purpura in children
EHA Library, Paul Imbach, 2141
Congenital platelet disorders
EHA Library, Marco Cattaneo, 2140
Blastic transformation in myeloproliferative disorders: science and therapy
EHA Library, Ruben Mesa, 2139
Management of primary myelofibrosis
EHA Library, Giovanni Barosi, 2138
Stratified management of essential thrombocythemia and polycythemia vera
EHA Library, Alessandro M. Vannucchi, 2137
Autoimmune neutropenia
EHA Library, Stephan Ehl, 2144
Chronic idiopathic neutropenia: clinical and pathophysiologic aspects
EHA Library, Helen Papadaki, 2145
Treatment of bleeding disorders with pro-hemostatic drugs
EHA Library, Jorgen Ingerslev, 2130
Evaluation of the severity of bleeding disorders
EHA Library, Francesco Rodeghiero, 2129
Past and present screening assays to evaluate hemostasis
EHA Library, Waander van Heerde, 2128
Hemostasis and cancer
EHA Library, Frederick Rickles, 2125
Clues on the origin and behaviour of chronic lymphocytic leukemia cells
EHA Library, Paolo Ghia, 2152
Prognostic markers in chronic lymphocytic leukemia
EHA Library, Jesper Jurlander, 2153
Using novel targeted drug therapy for front-line management of pediatric acute leukemia
EHA Library, Gregory Reaman, 2115
Characteristics and management of patients with very high risk childhood acute lymphoblastic leukemia
EHA Library, Martin Schrappe, 2114
Genes and proteins mediating drug resistance in acute lymphoblastic leukemia
EHA Library, Rob Pieters, 2113
New agents for the treatment of acute myeloid leukemia
EHA Library, Sergio Amadori, 2112
Genetic profiling and its impact on treatment of acute myeloid leukemia
EHA Library, Hartmut Döhner, 2111
Gene expression profiling to distinguish acute myeloid leukemia subtypes: discovery of a novel subtype with unique molecular and biological features
EHA Library, Ruud Delwel, 2110
The role of new agents in the management of chronic myeloid leukemia
EHA Library, Michael W Deininger, 2109
Imatinib resistance: the role of BCR-ABL dependent and BCR-ABL independent mechanisms in the loss of response to tyrosine kinase inhibitors
EHA Library, Giovanni Martinelli, 2108
Molecular mechanisms of transformation and leukemogenesis by BCR-ABL
EHA Library, Rick van Etten, 2107
Genomic instability in leukemia
EHA Library, Pier Guiseppe Pelicci, 1368
Gene therapy for red cell disorder
EHA Library, Michel Sadelain, 1367
Optimizing anti-thrombotic treatment: the role of new and established agents
EHA Library, Harry R. Büller, 1366
The JAK2 V617F mutation is present in a minority of human hematopoietic stem cells from patients with myeloproliferative disorders and does not modify their self-renewal properties
EHA Library, Chloé James, 1359
Primary allogeneic stem cell transplantation versus best available drug treatment in chronic myeloid leukemia
EHA Library, Rüdiger Hehlmann, 1357
Identification of the chromatin-remodeling protein SATB1 as a development-dependent long-range transcriptional regulator of the PU.1 gene
EHA Library, Ulrich Steidl, 1361
Stem cell banking
EHA Library, David Scadden, 1363
Stem cell banking
EHA Library, Wim Fibbe, 1364
Thrombophilia: from single gene disorder to complex disease
EHA Library, Rogier Bertina, 1365
Hydroxyurea: benefits and risks in patients affected with sickle cell anemia
EHA Library, Mariane de Montalembert, 1332
VKORC1: pharmacogenetics and oral anticoagulation
EHA Library, Johannes Oldenburg, 1315
Genome-wide approaches to identify new subtypes of acute myeloid leukemia (AML)
EHA Library, Peter VALK, 1354
Immunotherapy of leukemia with TCR gene modified T cells
EHA Library, Hans Stauss, 1349
The molecular and cellular basis for immunotherapeutic intervention in malignant disease: dynamic imaging of the immune system
EHA Library, Carina Lotz, 1348
Do arterial and venous thrombosis share common risk factors?
EHA Library, Gordon Lowe, 1316
Venous thromboembolism in medical patients: stratification and prevention
EHA Library, Paolo Prandoni, 1317
Pathology and genetics of T-cell lymphomas
EHA Library, Andreas Chott, 1321
Current treatment of T-cell lymphomas: are we making any progress?
EHA Library, Alain Delmer, 1322
Novel drugs for the treatment of T-cell lymphoma
EHA Library, Owen O'Connor, 1323
New developments in curative approaches in myelodysplasia
EHA Library, Theo De Witte, 1341
Epigenetic therapy in MDS
EHA Library, Pierre Fenaux, 1340
Molecular pathogenesis of myelodysplastic syndromes
EHA Library, Charlotte Niemeyer, 1339
Advances in myeloma biology: basis for new therapy
EHA Library, Nikhil Munshi, 1324
Multiple myeloma: diagnosis, staging and criteria of response
EHA Library, Joan Bladé, 1325
Novel treatment approaches in multiple myeloma
EHA Library, Antonio Palumbo, 1326
Detection of minimal residual disease in adult patients with acute lymphoblastic leukemia: methodological advances and clinical significance
EHA Library, Monika Brüggemann, 1335
Genetics of T-cell acute lymphoblastic leukemia
EHA Library, Christine Harrison, 1333
Hemolysis-associated pulmonary hypertension in sickle cell disease and thalassemia
EHA Library, Gregory Kato, 1330
The contribution of asthma to sickle cell disease related morbidity and mortality
EHA Library, Michael DeBaun, 1331
Human platelet alloantigens: heterogeneity of platelet alloantibodies
EHA Library, Sentot Santoso, 1351
New drugs for CLL
EHA Library, John Gribben, 1329
State-of-the-art treatment of chronic lymphocytic leukemia (CLL)
EHA Library, Michael Hallek, 1328
Genetics in CLL: Impact for prognosis and treatment decisions
EHA Library, Ulrich Jäger, 1327
Targeting critical pathways in leukemic stem cells
EHA Library, Brian Huntly, 1336
Clinical use of molecular markers in adult acute myeloid leukemia
EHA Library, Clara Bloomfield, 1337
Management of elderly patients with acute myeloid leukemia
EHA Library, Hervé Dombret, 1338
Clinical implications of ABL mutational screening
EHA Library, Justus Duyster, 1342
Management of patients with imatinib resistance
EHA Library, Eduardo Olavarria, 1344
Molecular pathogenesis of the myeloproliferative diseases
EHA Library, William Vainchenker, 1345
Treatment of relapsing / refractory patients with Hodgkin's lymphoma
EHA Library, Pauline Brice, 1320
Tailoring the treatment for early-stage Hodgkin's lymphoma
EHA Library, Marc Andre, 1319
The role of PET in staging and response assessment
EHA Library, Lena Specht, 1318
Diagnosis and classification of MPDs in the JAK2 era
EHA Library, Claire Harrison, 1346
Conventional and new treatment modalities in myelofibrosis
EHA Library, Francisco Cervantes, 1347
Laboratory diagnosis of neonatal alloimmune thrombocytopenia
EHA Library, Leendert Porcelijn, 1352
Gene therapy for hemophilia
EHA Library, Thierry Vandendriessche, 1314
Recent advances in hemophilia management
EHA Library, Claude Negrier, 1313
Epidemiology of coagulation disorders
EHA Library, Flora Peyvandi, 1312
Screening hemochromatosis and iron overload
EHA Library, Clara Camaschella, 1311
Mechanisms of iron regulation and of iron deficiency
EHA Library, Chaim Hershko, 1308

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings